CIK 0001390478
- Non-accelerated filer
- Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-200-5278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $716,682
- in 3 filings
Net −$716,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-12-31 | Ahn Mark J President & CEO | Other acquisition | +31,289 | $0.40 | $13K | 61,289 |
| 2011-12-07 | Lee Kwang Principal Accounting Officer | Purchase | +5,000 | $0.60 | $3K | 5,000 |
| 2011-12-07 | Ahn Mark J President & CEO | Purchase | +10,000 | $0.66 | $7K | 20,000 |
| 2011-09-27 | GALLIKER STEPHEN S Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2011-09-27 | Chin Richard Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2011-09-27 | KRIEGSMAN STEVEN A Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2011-09-27 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2011-09-27 | Nisi Rudolph Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2011-09-24 | Pavco Pamela Former VP Pharma Development | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2011-09-24 | Khvorova Anastasia Former CSO | Grant or award | +76,923 | 137,482 | ||
| 2011-09-07 | SCHWARTZ MARK W. EVP Chief Operating Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2011-04-20 | Ahn Mark J President and CEO | Purchase | +10,000 | $0.95 | $10K | 10,000 |
| 2011-04-13 | SCHWARTZ MARK W. EVP, Chief Operating Officer | Grant or award | +330,872 | 330,872 | ||
| 2011-04-13 | SCHWARTZ MARK W. EVP Chief Operating Officer | Grant or award | +337,661 | 337,661 | ||
| 2011-04-13 | SCHWARTZ MARK W. EVP Chief Operating Officer | Grant or award · Common Stock | +40,000 | 40,000 | ||
| 2011-04-13 | Kennedy Robert Eugene Vice President and CFO | Grant or award | +374,288 | 374,288 | ||
| 2011-04-13 | Kennedy Robert Eugene Vice President and CFO | Grant or award | +2,430 | 376,718 | ||
| 2011-04-13 | Kennedy Robert Eugene Vice President and CFO | Grant or award | +2,576 | 379,294 | ||
| 2011-04-13 | Kennedy Robert Eugene Vice President and CFO | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2011-04-13 | Hillsberg Sanford Director | Grant or award | +120,838 | 126,838 |
Page 20 of 29 · 580 trades